# Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean Delivery

> **NCT04305756** · NA · COMPLETED · sponsor: **University of Utah** · enrollment: 146 (actual)

## Conditions studied

- Thromboembolism
- Postpartum DVT
- Thrombosis

## Interventions

- **DRUG:** Enoxaparin

## Key facts

- **NCT ID:** NCT04305756
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-12
- **Primary completion:** 2021-12-15
- **Final completion:** 2021-12-15
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2022-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04305756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04305756, "Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean Delivery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04305756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*